Tyche Wealth Partners LLC Invests $745,000 in Colgate-Palmolive (NYSE:CL)

Tyche Wealth Partners LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 9,341 shares of the company's stock, valued at approximately $745,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Vest Financial LLC grew its position in shares of Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company's stock worth $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. increased its stake in Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company's stock valued at $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC increased its stake in Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company's stock valued at $864,000 after purchasing an additional 910 shares in the last quarter. Sarasin & Partners LLP raised its holdings in Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company's stock worth $323,115,000 after purchasing an additional 49,980 shares during the period. Finally, Cornerstone Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 2.5% in the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company's stock valued at $571,000 after buying an additional 172 shares during the period. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the company's stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the sale, the director now owns 19,272 shares in the company, valued at $1,628,484. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the sale, the executive vice president now owns 8,043 shares of the company's stock, valued at approximately $686,470.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director C Martin Harris sold 2,760 shares of the stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock worth $19,505,099 over the last quarter. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Up 0.7 %

Shares of NYSE CL traded up $0.60 during mid-day trading on Wednesday, hitting $86.77. The company had a trading volume of 3,885,531 shares, compared to its average volume of 4,547,918. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The firm has a 50-day simple moving average of $86.97 and a two-hundred day simple moving average of $80.63. The company has a market capitalization of $71.32 billion, a PE ratio of 31.21, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same period last year, the company earned $0.77 earnings per share. The business's revenue was up 6.9% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.30%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive's dividend payout ratio is 69.06%.

Analysts Set New Price Targets

CL has been the topic of several research analyst reports. Citigroup raised their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday. Barclays raised their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an "equal weight" rating in a research report on Friday, April 12th. Evercore ISI boosted their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an "outperform" rating in a research report on Monday, April 8th. The Goldman Sachs Group initiated coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They set a "buy" rating and a $93.00 target price on the stock. Finally, Stifel Nicolaus increased their price objective on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a "buy" rating in a research report on Wednesday, April 10th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.